1. The bendamustine plus rituximab regimen is active against primary nodal marginal zone B‐cell lymphoma. Issue 4 (22nd July 2016) Authors: Laribi, Kamel; Tempescul, Adrien; Ghnaya, Habib; Denizon, Nathalie; Besançon, Anne; Anghel, Andreea; Farhi, Jonathan; Truong, Catherine; Lemaire, Pierre; Poulain, Stephanie; Bolle, Delphine; Ianotto, Jean Christophe; Baugier de Materre, Alix Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗